Prion diseases are a group of devastating pathologies that are still shrouded in mystery. Despite their importance, prions do not have a specific genome, and the mechanisms of their transmission and pathogenesis remain unclear.

At our lab, we are committed to addressing these challenges by conducting cutting-edge research aimed at developing effective therapeutic agents and screening tests for undiagnosed cases of prion diseases. We utilize the latest techniques and technologies to explore the molecular basis of prion diseases and develop innovative approaches to combat them.

As a researcher, my interests have evolved from parasites to viruses and prions, but my fundamental motivation has remained the same since my undergraduate years: to better understand the complex interactions between pathogens and their hosts.

Currently, my work focuses on elucidating the mechanisms of pathogenesis and progression of prion diseases and progressive multifocal leukoencephalopathy (PML). By combining cutting-edge techniques in molecular biology and neurobiology, we aim to unravel the intricate processes that underlie these devastating diseases and develop effective treatments for those affected. I am grateful for the opportunity to contribute to this important field.

• Prion detection by RT-QuIC assay
• PSC and brain organoid derived from genetic CJD patients